Tokyo, May 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061492) titled 'Survey on Real-World Usage of a Mobile Application for Self-Management of Chronic Heart Failure' on May 8.
Study Type:
Observational
Primary Sponsor:
Institute - Mie University
Condition:
Condition - Chronic heart failure
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate usage patterns of the app following its release by analysing life log data (e.g. daily blood pressure, pulse and weight) and heart failure symptom data obtained from patients with chronic heart failure who have installed and used the app. The app is being released on a limited basis. The aim is to use the feedback and evaluations received to improve the programming, user interface (UI) and user experience (UX) of the app in future versions.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Patients diagnosed with chronic heart failure (regardless of treatment or underlying conditions)
2) Owners of a smartphone capable of connecting to the internet
3) Individuals who have provided informed consent to participate in the study
4) Aged 18 years or older
Key exclusion criteria - 1) Patients who are unable to use a smartphone (or use the app) due to cognitive or physical decline or impairment;
2) Patients who have withdrawn their consent to participate in this study;
3) Patients whom the principal investigator or co-investigator deems unsuitable for inclusion in the study
Target Size - 300
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 05 Month 08 Day
Date of IRB - 2026 Year 05 Month 08 Day
Anticipated trial start date - 2026 Year 06 Month 01 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070364
Disclaimer: Curated by HT Syndication.
